Log in


+0.19 (+20.88 %)
(As of 06/5/2020 04:00 PM ET)
Today's Range
Now: $1.10
50-Day Range
MA: $0.79
52-Week Range
Now: $1.10
Volume55.45 million shs
Average Volume3.94 million shs
Market Capitalization$29.03 million
P/E RatioN/A
Dividend YieldN/A
Foresight Autonomous Holdings Ltd., a technology company, designs, develops, and commercializes stereo/quad-camera vision systems and V2X cellular-based solutions for the automotive industry in Israel. It develops advanced driver assistance systems for accident prevention, which are designed to provide real-time information about a vehicle's surroundings while in motion. The company was formerly known as Asia Development (A.D.B.M.) Ltd. and changed its name to Foresight Autonomous Holdings Ltd. in 2016. Foresight Autonomous Holdings Ltd. was founded in 2015 and is headquartered in Ness Ziona, Israel.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars

Industry, Sector and Symbol

Industry Prepackaged software
Current SymbolNASDAQ:FRSX



Sales & Book Value

Annual SalesN/A
Book Value$0.62 per share


Net Income$-15,440,000.00


Market Cap$29.03 million
Next Earnings Date8/14/2020 (Estimated)
OptionableNot Optionable

Receive FRSX News and Ratings via Email

Sign-up to receive the latest news and ratings for FRSX and its competitors with MarketBeat's FREE daily newsletter.

FORESIGHT AUTON/S (NASDAQ:FRSX) Frequently Asked Questions

How has FORESIGHT AUTON/S's stock been impacted by COVID-19 (Coronavirus)?

FORESIGHT AUTON/S's stock was trading at $0.6501 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, FRSX shares have increased by 69.2% and is now trading at $1.10. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of FORESIGHT AUTON/S?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for FORESIGHT AUTON/S in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for FORESIGHT AUTON/S.

When is FORESIGHT AUTON/S's next earnings date?

FORESIGHT AUTON/S is scheduled to release its next quarterly earnings announcement on Friday, August 14th 2020. View our earnings forecast for FORESIGHT AUTON/S.

How were FORESIGHT AUTON/S's earnings last quarter?

FORESIGHT AUTON/S (NASDAQ:FRSX) issued its earnings results on Thursday, May, 21st. The company reported ($0.13) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($0.14) by $0.01. View FORESIGHT AUTON/S's earnings history.

What price target have analysts set for FRSX?

2 brokers have issued 1 year target prices for FORESIGHT AUTON/S's stock. Their forecasts range from $7.00 to $7.00. On average, they anticipate FORESIGHT AUTON/S's share price to reach $7.00 in the next year. This suggests a possible upside of 536.4% from the stock's current price. View analysts' price targets for FORESIGHT AUTON/S.

Has FORESIGHT AUTON/S been receiving favorable news coverage?

Press coverage about FRSX stock has trended somewhat negative on Saturday, according to InfoTrie Sentiment. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. FORESIGHT AUTON/S earned a news sentiment score of -1.1 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View the latest news aboutFORESIGHT AUTON/S.

Who are some of FORESIGHT AUTON/S's key competitors?

What other stocks do shareholders of FORESIGHT AUTON/S own?

Based on aggregate information from My MarketBeat watchlists, some companies that other FORESIGHT AUTON/S investors own include Ring Energy (REI), Ring Energy (REI), Alibaba Group (BABA), Corbus Pharmaceuticals (CRBP), AbbVie (ABBV), AcelRx Pharmaceuticals (ACRX), Actinium Pharmaceuticals (ATNM), Atara Biotherapeutics (ATRA), Avinger (AVGR) and Baidu (BIDU).

Who are FORESIGHT AUTON/S's key executives?

FORESIGHT AUTON/S's management team includes the following people:
  • Mr. Haim Siboni, CEO & Director (Age 60)
  • Mr. Eli Yoresh, Chief Financial Officer (Age 49)
  • Mr. Ariel Dor, VP of Mergers & Acquisitions (Age 37)
  • Mr. Doron Cohadier, VP of Bus. Devel. (Age 44)
  • Mr. Dror Elbaz, COO & Deputy CEO of Eye-Net Mobile Ltd (Age 40)

What is FORESIGHT AUTON/S's stock symbol?

FORESIGHT AUTON/S trades on the NASDAQ under the ticker symbol "FRSX."

Who are FORESIGHT AUTON/S's major shareholders?

FORESIGHT AUTON/S's stock is owned by many different retail and institutional investors. Top institutional investors include Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD (0.45%).

Which major investors are buying FORESIGHT AUTON/S stock?

FRSX stock was acquired by a variety of institutional investors in the last quarter, including Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD.

How do I buy shares of FORESIGHT AUTON/S?

Shares of FRSX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is FORESIGHT AUTON/S's stock price today?

One share of FRSX stock can currently be purchased for approximately $1.10.

How big of a company is FORESIGHT AUTON/S?

FORESIGHT AUTON/S has a market capitalization of $29.03 million.

What is FORESIGHT AUTON/S's official website?

The official website for FORESIGHT AUTON/S is www.foresightauto.com.

How can I contact FORESIGHT AUTON/S?

FORESIGHT AUTON/S's mailing address is 7 GOLDA MEIR STREET, NESS ZIONA L3, 7403650. The company can be reached via phone at 972-77-970-9030 or via email at [email protected]

This page was last updated on 6/6/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.